138 related articles for article (PubMed ID: 38631160)
1. Corrigendum to "Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study" [Sleep Med. 109 (2023) 65-74 ISSN 1389-9457].
Bae CJ; Zee PC; Leary EB; Fuller DS; Macfadden W; Candler S; Steininger TL; Husain AM
Sleep Med; 2024 Jul; 119():17-18. PubMed ID: 38631160
[No Abstract] [Full Text] [Related]
2. Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study.
Bae CJ; Zee PC; Leary EB; Fuller DS; Macfadden W; Candler S; Steininger TL; Husain AM
Sleep Med; 2023 Sep; 109():65-74. PubMed ID: 37421868
[TBL] [Abstract][Full Text] [Related]
3. Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study.
Husain AM; Zee PC; Leary EB; Fuller DS; Macfadden W; Candler S; Whalen M; Bae CJ
Sleep Med; 2024 Jan; 113():328-337. PubMed ID: 38103464
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate.
Schneider LD; Morse AM; Strunc MJ; Lee-Iannotti JK; Bogan RK
Nat Sci Sleep; 2023; 15():663-675. PubMed ID: 37621721
[TBL] [Abstract][Full Text] [Related]
5. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
Roth T; Thorpy MJ; Kushida CA; Horsnell M; Gudeman J
J Comp Eff Res; 2023 Dec; 12(12):e230133. PubMed ID: 37971303
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the SEGUE study.
Macfadden W; Leary EB; Fuller DS; Kirby MT; Roy A
J Clin Sleep Med; 2024 Apr; ():. PubMed ID: 38652499
[TBL] [Abstract][Full Text] [Related]
7. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Black J; Pardi D; Hornfeldt CS; Inhaber N
Sleep Med; 2009 Sep; 10(8):829-35. PubMed ID: 19616998
[TBL] [Abstract][Full Text] [Related]
8. The effects of sodium oxybate on core body and skin temperature regulation in narcolepsy.
van der Heide A; Donjacour CE; Pijl H; Reijntjes RH; Overeem S; Lammers GJ; Van Someren EJ; Fronczek R
J Sleep Res; 2015 Oct; 24(5):566-75. PubMed ID: 25913575
[TBL] [Abstract][Full Text] [Related]
9. Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture.
Roth T; Dauvilliers Y; Bogan RK; Plazzi G; Black J
Sleep Med; 2024 Feb; 114():255-265. PubMed ID: 38244463
[TBL] [Abstract][Full Text] [Related]
10. Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav
Heo YA
CNS Drugs; 2022 May; 36(5):541-549. PubMed ID: 35357671
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
Bogan RK; Foldvary-Schaefer N; Skowronski R; Chen A; Thorpy MJ
CNS Drugs; 2023 Apr; 37(4):323-335. PubMed ID: 36947322
[TBL] [Abstract][Full Text] [Related]
12. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy.
Mamelak M; Black J; Montplaisir J; Ristanovic R
Sleep; 2004 Nov; 27(7):1327-34. PubMed ID: 15586785
[TBL] [Abstract][Full Text] [Related]
13. Long-term compliance, safety, and tolerability of sodium oxybate treatment in patients with narcolepsy type 1: a postauthorization, noninterventional surveillance study.
Mayer G; Plazzi G; Iranzo Á; Ortega-Albás J; Quinnell T; Pesch H; Serralheiro P; Schlit AF; Wuiame D; Bentz JWG
Sleep; 2018 Sep; 41(9):. PubMed ID: 29986085
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial evaluating the effectiveness of sodium oxybate therapy on quality of life in narcolepsy.
Weaver TE; Cuellar N
Sleep; 2006 Sep; 29(9):1189-94. PubMed ID: 17040006
[TBL] [Abstract][Full Text] [Related]
15. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
16. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
Junnarkar G; Allphin C; Profant J; Steininger TL; Chen C; Zomorodi K; Skowronski R; Black J
Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
[TBL] [Abstract][Full Text] [Related]
17. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
Dauvilliers Y; Šonka K; Bogan RK; Partinen M; Del Rio Villegas R; Foldvary-Schaefer N; Skowronski R; Chen A; Black J; Skobieranda F; Thorpy MJ
CNS Drugs; 2022 Jun; 36(6):633-647. PubMed ID: 35635687
[TBL] [Abstract][Full Text] [Related]
18. The cost-utility of sodium oxybate as narcolepsy treatment.
Bolin K; Berling P; Wasling P; Meinild H; Kjellberg J; Jennum P
Acta Neurol Scand; 2017 Dec; 136(6):715-720. PubMed ID: 28677318
[TBL] [Abstract][Full Text] [Related]
19. Improved vigilance after sodium oxybate treatment in narcolepsy: a comparison between in-field and in-laboratory measurements.
van Schie MK; Werth E; Lammers GJ; Overeem S; Baumann CR; Fronczek R
J Sleep Res; 2016 Aug; 25(4):486-96. PubMed ID: 26909768
[TBL] [Abstract][Full Text] [Related]
20. An evaluation of sodium oxybate as a treatment option for narcolepsy.
Abad VC
Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
